BR9713540A - Procedimento para a expressão do gene do vìrus da dengue - Google Patents
Procedimento para a expressão do gene do vìrus da dengueInfo
- Publication number
- BR9713540A BR9713540A BR9713540-2A BR9713540A BR9713540A BR 9713540 A BR9713540 A BR 9713540A BR 9713540 A BR9713540 A BR 9713540A BR 9713540 A BR9713540 A BR 9713540A
- Authority
- BR
- Brazil
- Prior art keywords
- dengue
- virus
- expression
- procedure
- serotype
- Prior art date
Links
- 241000725619 Dengue virus Species 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 208000001490 Dengue Diseases 0.000 abstract 4
- 206010012310 Dengue fever Diseases 0.000 abstract 4
- 208000025729 dengue disease Diseases 0.000 abstract 4
- 241000700605 Viruses Species 0.000 abstract 3
- 101710091045 Envelope protein Proteins 0.000 abstract 2
- 101710204837 Envelope small membrane protein Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 101710188315 Protein X Proteins 0.000 abstract 2
- 102100021696 Syncytin-1 Human genes 0.000 abstract 2
- 101710145006 Lysis protein Proteins 0.000 abstract 1
- 241000235648 Pichia Species 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 101710088839 Replication initiation protein Proteins 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 230000002008 hemorrhagic effect Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24161—Methods of inactivation or attenuation
- C12N2710/24162—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Patente de Invenção: <B>"PROCEDIMENTO PARA A EXPRESSãO DE GENES DO VìRUS DA DENGUE"<D>. A presente invenção está no campo da biotecnologia e refere-se a técnicas de DNA recombinantes, em particular a um procedimento para a expressão do gene que codifica a proteína do envelope do vírus da dengue sorotipo 2 e 4 em levedura metilotrófica de gênero Pichia. O objetivo técnico é desenvolver um sistema para a expressão eficiente do gene que codifica a proteína do envelope do vírus da dengue sorotipo 2 e 4 para obter um imunógeno para vacinação humana. A seq³ência genética que codifica a proteína E do vírus foi o ponto de partida do vírus da dengue sorotipo 2, retirada da cepa A 15 isolada durante as epidemias de febre de dengue e dengue hemorrágica em Cuba, 1981. Para o vírus da dengue sorotipo 4 o ponto de partida foi seq³ência genética que codifica a proteína E do vírus tirada da cepa 814669 isolada durante a epidemia de febre da dengue na República Dominicana em 1981.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU1996107A CU22666A1 (es) | 1996-11-25 | 1996-11-25 | Procedimiento para la expresión de genes de los virus del dengue en la levadura pichia pastoris, adns recombinantes y microorganismos transformados |
PCT/CU1997/000006 WO1998023754A1 (es) | 1996-11-25 | 1997-11-25 | Procedimiento para la expresion de genes de los virus del dengue |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9713540A true BR9713540A (pt) | 2000-10-24 |
Family
ID=46093346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9713540-2A BR9713540A (pt) | 1996-11-25 | 1997-11-25 | Procedimento para a expressão do gene do vìrus da dengue |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN1258317A (pt) |
AU (1) | AU5397398A (pt) |
BR (1) | BR9713540A (pt) |
CU (1) | CU22666A1 (pt) |
WO (1) | WO1998023754A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU23245A1 (es) | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
KR101042458B1 (ko) * | 2001-12-04 | 2011-06-16 | 벤처 테크놀로지스 에스디엔 비에이치디 | 플라비바이러스 ns1 서브유닛 백신 |
CU23578A1 (es) | 2005-09-16 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal |
CU23586A1 (es) * | 2005-11-22 | 2010-10-30 | Ct Ingenieria Genetica Biotech | Métodos y proteínas para el tratamiento profiláctico y/o terapéutico de los cuatro serotipos del virus de dengue y otros flavivirus |
CU23630A1 (es) | 2006-10-30 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae |
CN102363751A (zh) * | 2011-03-24 | 2012-02-29 | 中山大学 | 登革病毒样颗粒及其制备方法与应用 |
CN103103293B (zh) * | 2013-02-01 | 2014-04-16 | 中华人民共和国北京出入境检验检疫局 | 登革2型病毒纳米磁分离实时荧光定量pcr检测试剂盒及核苷酸序列 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE227584T1 (de) * | 1995-05-24 | 2002-11-15 | Hawaii Biotech Group | Untereinheitsimpfstoff gegen flavivirus infektion |
-
1996
- 1996-11-25 CU CU1996107A patent/CU22666A1/es unknown
-
1997
- 1997-11-25 CN CN97181246A patent/CN1258317A/zh active Pending
- 1997-11-25 WO PCT/CU1997/000006 patent/WO1998023754A1/es active Application Filing
- 1997-11-25 AU AU53973/98A patent/AU5397398A/en not_active Abandoned
- 1997-11-25 BR BR9713540-2A patent/BR9713540A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1998023754A1 (es) | 1998-06-04 |
CU22666A1 (es) | 2001-04-27 |
AU5397398A (en) | 1998-06-22 |
CN1258317A (zh) | 2000-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2468080C2 (ru) | Новый класс терапевтических белковых молекул | |
RU2351651C2 (ru) | Выделенный рекомбинантный вирус гриппа и способы его получения | |
BR9712852A (pt) | Plasmìdeo, composição, processo de imunização de um indivìduo contra um patógeno, vacina recombinante, patógeno vivo atenuado, proteìna bl-1 substancialmente pura, vetor recombinante de expressão, e, anticorpo isolado | |
BR9608241A (pt) | Proteìna de membrana externa maior de moraxella com alto peso molecular | |
BR9814276A (pt) | Antìgenos de superfìcie | |
NO20070618L (no) | Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose. | |
ATE386800T1 (de) | Immunogene chimäre umfassend nucleinsäuresequenzen, die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten | |
AR008727A1 (es) | COMPOSICIONES Y PROTEINAS DE FUSIoN QUE COMPRENDEN UN POLIPEPTIDO QUE COMPRENDE UNA PORCION INMUNOGENICA DE UNA PROTEINA DE PROSTATA O SU VARIANTE, Y USOS DE LAS MISMAS PARA PREPARAR UN MEDICAMENTO | |
CA2228221A1 (en) | Papillomavirus polyprotein constructs | |
DE60043299D1 (de) | Proteinfragmente die polyepitope des nef proteins von hiv umfassen, deren herstellung und verwendungen insbesondere zur impfung | |
DE69536039D1 (de) | Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert | |
US5571718A (en) | Cloning and expression of soluble truncated variants of Borrelia OspA, OspB and Vmp7 | |
BR9809914A (pt) | Genes de moracella receptores de lactoferrina | |
HK1053985A1 (zh) | 人類多肽引起或導致殺死細胞,包括淋巴腫瘤細胞 | |
RU2009123028A (ru) | F-белок респираторно-синцитиального вируса (rsv) и его применение | |
Hsu et al. | Oral administration of a mite allergen expressed by zucchini yellow mosaic virus in cucurbit species downregulates allergen-induced airway inflammation and IgE synthesis | |
HUP0105379A2 (hu) | Lawsonia intracellularis elleni oltóanyag | |
BR9712556A (pt) | Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno | |
US20030050463A1 (en) | Production of a parvovirus vaccine in plants as viral coat protein fusions | |
BR9713540A (pt) | Procedimento para a expressão do gene do vìrus da dengue | |
HUP9801334A2 (hu) | A 18-as típusú humán papillomavírust kódoló DNS | |
ES2287067T3 (es) | Vacunas que contienen polipeptidos hibridos que consisten en al menos dos proteinas alergenicas diferentes. | |
WO2007091387A1 (ja) | Hla結合性ペプチド、その前駆体、それをコードするdna断片および組み換えベクター | |
FI902569A0 (fi) | Producering av till gonorre anslutande pi-proteiner och vaccin. | |
BR0112020A (pt) | Partìculas tipo vìrus de bvdv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1894 DE 24/04/2007. |